U.S. Supreme Court Declines to Review Decision Allowing Asbestos Claims Against Pfizer Despite Bankruptcy Injunction

WASHINGTON, D.C. –– The U.S. Supreme Court has denied Pfizer, Inc.’s (NYSE:PFE) petition for writ of certiorari, declining to review a decision allowing asbestos claims involving exposure to a product manufactured by the company’s bankrupt subsidiary to proceed.

The nation’s highest court denied the petition on June 24, according to the court’s online docket.

The U.S. Court of Appeals for the 2nd Circuit upheld an April 2012 decision by the U.S. District Court for the Southern District of New York finding that the claims filed against Pfizer were outside the scope of an injunction issued by the bankruptcy court.